Evaluating the Curative Effect of Ultrasound-guided Sclerotherapy with Foam Lauromacrogol for Uterine Fibroids

doi:10.37015/AUDT.2021.190030

Abstract

Abstract:

Objective: To evaluate the curative effect of lauromacrogol foam sclerotherapy of uterine fibroids via transvaginal ultrasound-guided injection.
Methods: Thirty premenopausal women with a total of thirty-one uterine fibroids were recruited consecutively and underwent transvaginal 3D-Power Doppler Angiography (PDA) at 0, 1, 3, and 6 months. Written informed consent was obtained from all of the patients. The changes in the fibroid 3D volume and relationships between the fibroid location and blood supply were analyzed. The relief of clinical symptoms and improvement in health-related quality of life (HRQL) were evaluated using the uterine fibroid symptom and quality-of-life (UFS-QOL) questionnaire before and after treatment for 6 months; adverse events were also assessed.
Results: The mean baseline volumes ± SD were 61.2 ± 71.5 cm³ (range, 4.1 cm³ - 340.4 cm³) for the dominant fibroid. The mean values of percentage reduction in fibroid volume at 1, 3 and 6 months were 23.9% (range, 5.2% - 42.1%; 95%CI, 20.6% - 27.3%), 43.4% (range, 21.8% - 67.4%; 95%CI, 39.0% - 47.8%), and 60.0% (range, 31.8% - 83.2%; 95%CI, 55.2% - 64.9%), respectively, and the reduction was correlated with the location and blood supply. Additionally, the blood flow to the fibroids was markedly decreased. The clinical symptoms were greatly alleviated or even completely resolved, and the HRQL was notably improved (P < 0.001). Mild abdominal pain, paleness, vomiting, and cold sweat were most commonly reported adverse effects.
Conclusion: Ultrasound-guided sclerotherapy of uterine fibroids with foam lauromacrogol is a simple, safe and useful method with a wide application prospect.

Key words: Uterine fibroid; Ultrasound-guided; Lauromacrogol; Sclerotherapy

Juan Gao, MS, Yanggui Xie, MS, Bo Liang, MD, Xiaoqin Qian, MD. Evaluating the Curative Effect of Ultrasound-guided Sclerotherapy with Foam Lauromacrogol for Uterine Fibroids. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(1): 32-38.

References

[1]	Solbiati L, Ahmed M, Cova L, Ierace T, Brioschi M, Goldberg SN. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 2012; 265:958-68.
[2]	Rabe E, Pannier F. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology. Dermatol Surg 2010; 36 Suppl 2: 968-75.
[3]	Sato T, Yamazaki K, Akaike J, Toyota J, Karino Y, Ohmura T. Retrospective analysis of endoscopic injection sclerotherapy for rectal varices compared with band ligation. Clin Exp Gastroenterol 2010; 3:159-63.
[4]	Zhou X, Xie Y, Cui Q, Xu X, He M, Liang B. [Safety and efficacies of ultrasound-guided sclerotherapy of uterine fibroids with lauromacrogol]. Zhonghua Yi Xue Za Zhi 2014; 94:2204-6.
[5]	Ikponmwosa A, Abbott C, Graham A, Homer-Vanniasinkam S, Gough MJ. The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclerotherapy. Eur J Vasc Endovasc Surg 2010; 39:366-71.
[6]	Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002; 28:11-5.
[7]	Adler DD, Carson PL, Rubin JM, Quinn-Reid D. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings. Ultrasound Med Biol 1990; 16:553-9.
[8]	Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002; 99:290-300.
[9]	Gomez-Jorge J, Keyoung A, Levy EB, Spies JB. Uterine artery anatomy relevant to uterine leiomyomata embolization. Cardiovasc Intervent Radiol 2003; 26:522-7.
[10]	Muniz CJ, Fleischer AC, Donnelly EF, Mazer MJ. Three-dimensional color Doppler sonography and uterine artery arteriography of fibroids: assessment of changes in vascularity before and after embolization. J Ultrasound Med 2002; 21:129-33.
[11]	Merce LT, Alcazar JL, Engels V, Troyano J, Bau S, Bajo JM. Endometrial volume and vascularity measurements by transvaginal three-dimensional ultrasonography and power Doppler angiography in stimulated and tumoral endometria: intraobserver reproducibility. Gynecol Oncol 2006; 100:544-50.
[12]	Hamper UM, Trapanotto V, DeJong MR, Sheth S, Caskey CI. Three-dimensional US of the prostate: early experience. Radiology 1999; 212:719-23.
[13]	Riccabona M, Nelson TR, Pretorius DH. Three-dimensional ultrasound: accuracy of distance and volume measurements. Ultrasound Obstet Gynecol 1996; 7:429-34.
[14]	Alcázar JL, Prka M. Evaluation of two different methods for vascular sampling by three-dimensional power Doppler angiography in solid and cystic-solid adnexal masses. Ultrasound Obstet Gynecol 2009; 33:349-54.
[15]	Peng S, Xiong Y, Li K, He M, Deng Y, Chen L, et al. Clinical utility of a microbubble-enhancing contrast ("SonoVue") in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study. Eur J Radiol 2012; 81:3832-8.
[16]	Seinera P, Arisio R, Decko A, Farina C, Crana F. Laparoscopic myomectomy: indications, surgical technique and complications. Hum Reprod 1997; 12:1927-30.
[17]	Spies JB, Cooper JM, Worthington-Kirsch R, Lipman JC, Mills BB, Benenati JF. Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 2004; 191:22-31.
[18]	Coakley FV, Foster BR, Farsad K, Hung AY, Wilder KJ, Amling CL, et al. Pelvic applications of MR-guided high intensity focused ultrasound. Abdom Imaging 2013; 38:1120-9.